OLMETN-20

Description

OLMETN-20 contains Olmesartan Medoxomil 20 mg in tablet form. Olmesartan medoxomil belongs to the angiotensin II receptor blocker (ARB) class and helps lower blood pressure by blocking the action of angiotensin II, a hormone that causes blood vessels to constrict. As a result, the medicine supports blood pressure management in adults with hypertension when prescribed by a healthcare professional.

For related cardiovascular and antihypertensive formulations, explore the Medhexa Pharma product range for pharmaceutical products and business enquiries.

Therapeutic Segment

Cardiovascular Care | Antihypertensive Therapy | Blood Pressure Management | ARBs | Hypertension Management

Uses of OLMETN-20

Healthcare professionals may prescribe OLMETN-20 as part of a treatment plan for:

• High blood pressure (hypertension)
• Long-term blood pressure management
• Patients requiring ARB therapy
• Blood pressure control when lifestyle measures alone do not provide adequate control
• Hypertension management as part of an individualized cardiovascular-care plan

Olmesartan medoxomil can be used alone or together with other antihypertensive medicines, depending on the patient’s blood pressure and clinical needs.

Key Benefits of OLMETN-20

• Blood Pressure Management: Helps lower elevated blood pressure when prescribed appropriately.
• ARB Action: Blocks angiotensin II receptors involved in blood vessel constriction.
• 20 mg Strength: Provides Olmesartan Medoxomil 20 mg in each tablet.
• Supports Vasodilation: By blocking angiotensin II activity, olmesartan helps blood vessels remain more relaxed.
• Oral Tablet Form: Provides a convenient oral dosage form.
• Long-Term Therapy: May form part of an ongoing hypertension-management plan under medical supervision.

How OLMETN-20 Works

Olmesartan Medoxomil is an angiotensin II receptor blocker. After administration, olmesartan medoxomil converts to the active compound olmesartan.

Olmesartan selectively blocks the AT1 receptor, which mediates many of the effects of angiotensin II. Consequently, it reduces angiotensin II-driven blood vessel constriction and aldosterone-related effects. This helps lower blood pressure.

Therefore, OLMETN-20 supports blood pressure control through targeted blockade of the renin-angiotensin system.

Common Side Effects of OLMETN-20

Some people may experience side effects during treatment. Possible effects include:

• Dizziness
• Headache
• Fatigue
• Diarrhoea
• Back pain
• Nausea
• Low blood pressure
• Increased blood potassium levels

Dizziness can occur when blood pressure falls, particularly when treatment begins or when the patient has low fluid or salt levels. Healthcare professionals may monitor blood pressure, kidney function and electrolytes when appropriate.

Important Safety Information

Use OLMETN-20 only according to the advice of a qualified healthcare professional.

Blood Pressure and Dizziness

Olmesartan can lower blood pressure. Patients who have low fluid or salt levels, including those taking diuretics, may have a greater risk of symptomatic low blood pressure when treatment begins.

Kidney Function and Potassium

Olmesartan can affect kidney function and potassium levels in susceptible patients. Tell your healthcare professional if you have kidney disease or are taking medicines or supplements that can increase potassium.

Pregnancy

Olmesartan should not be used during pregnancy. Drugs that act directly on the renin-angiotensin system can cause fetal injury or death. If pregnancy is detected, medical advice should be obtained promptly regarding discontinuation and alternative treatment.

Rare Gastrointestinal Effects

Olmesartan has been associated with rare sprue-like enteropathy, which can cause persistent diarrhoea and weight loss. If severe or persistent gastrointestinal symptoms develop, contact a healthcare professional.

Drug Interactions

Tell your doctor or pharmacist about all medicines and supplements you take. Particular attention may be required with potassium supplements, potassium-containing salt substitutes, diuretics, other medicines affecting the renin-angiotensin system and certain anti-inflammatory medicines.

Olmesartan should not be co-administered with aliskiren in patients with diabetes.

For detailed prescribing information, refer to the DailyMed prescribing information for Olmesartan Medoxomil.

Dosage & Administration

Take OLMETN-20 exactly as prescribed by your healthcare professional.

For adult hypertension, current prescribing information lists 20 mg once daily as the usual starting dose, with a dose range of 20–40 mg once daily depending on the patient’s response and clinical requirements.

Healthcare professionals may adjust treatment according to blood pressure response and individual patient factors. Patients with possible fluid or salt depletion may require closer supervision when treatment begins.

Take the tablet according to the prescribed schedule. Do not increase the dose, stop treatment or take additional tablets without medical advice.

Storage

• Store OLMETN-20 in a cool, dry place.
• Protect the tablets from excessive heat and moisture.
• Keep the tablets in their original ALU-ALU packaging until use.
• Protect from direct sunlight.
• Keep out of the sight and reach of children.
• Do not use the product after the expiry date printed on the pack.